This effect drastically decreased when glioblastoma cells were transfected with siRNAs specifically targeting CXCL16 prior to stimulation with recombinant CXCR6 (Figure 2B, in comparison to control siRNA transfections), indicating a specific signaling mechanism via CXCL16. The gene discussed is CXCL16; the disease is glioblastoma.